# Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

> **NCT00380237** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 20 (actual)

## Conditions studied

- Influenza
- Virus Diseases

## Interventions

- **BIOLOGICAL:** H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)

## Key facts

- **NCT ID:** NCT00380237
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380237, "Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00380237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*